XENE

XENE

USD

Xenon Pharmaceuticals Inc. Common Shares

$39.090-0.650 (-1.636%)

Echtzeitkurs

Healthcare
Biotechnologie
Kanada

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$39.740

Hoch

$40.450

Tief

$37.625

Volumen

0.18M

Unternehmensfundamentaldaten

Marktkapitalisierung

3.0B

Branche

Biotechnologie

Land

Canada

Handelsstatistiken

Durchschnittliches Volumen

0.79M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $26.74Aktuell $39.090Hoch $46

Ähnliche Nachrichten

Analyst Upgrades

RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Raises Price Target to $58

RBC Capital analyst Brian Abrahams maintains Xenon Pharmaceuticals with a Outperform and raises the price target from $55 to $58.

Mehr anzeigen
RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Raises Price Target to $58
Analyst Upgrades

Wells Fargo Maintains Overweight on Xenon Pharmaceuticals, Lowers Price Target to $44

Wells Fargo analyst Benjamin Burnett maintains Xenon Pharmaceuticals with a Overweight and lowers the price target from $48 to $44.

Mehr anzeigen
Wells Fargo Maintains Overweight on Xenon Pharmaceuticals, Lowers Price Target to $44
Analyst Upgrades

Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $55 Price Target

Needham analyst Serge Belanger reiterates Xenon Pharmaceuticals with a Buy and maintains $55 price target.

Mehr anzeigen
Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $55 Price Target
GlobeNewswire

Xenon to Report Q3 2025 Financial Results on November 3, 2025

VANCOUVER, British Columbia and BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and

Mehr anzeigen
Xenon to Report Q3 2025 Financial Results on November 3, 2025